Search Within

Olivier De Henau

Formats
  1. Meeting Abstract (9)
  2. Journal Article (4)
Groups
  1. Department of Medicine (13)
  2. GSK Faculty (13)
  3. Melanoma and Immunotherapeutics Service (13)
  4. Sloan Kettering Institute Postdocs (13)
  5. Solid Tumor Oncology Division (13)
  6. Weinberg Fellows (6)

More Groups

People
  1. Jedd Wolchok (13)
  2. Sadna Budhu (13)
  3. Taha Merghoub (13)
  4. Roberta Zappasodi (10)
  5. Cailian Liu (7)
  6. Daniel Hirschhorn Cymerman (7)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2019 (1)
  4. 2018 (4)
  5. 2017 (2)
  6. 2016 (2)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (6)
  2. Journal of Immunology (2)
  3. Advances in Cancer Research (1)
  4. Cancer Research (1)
  5. Cell Reports (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. Biomed Central Ltd (6)
  2. The American Association of Immunologists, Inc (2)
  3. Academic Press, Elsevier Inc (1)
  4. American Association for Cancer Research (1)
  5. American Society for Clinical Investigation (1)
  6. Cell Press (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma
    Journal Article

    Budhu, S.; Giese, R.; Gupta, A.; Fitzgerald, K.; Zappasodi, R.; Schad, S.; Hirschhorn, D.; Campesato, L. F.; De Henau, O.; Gigoux, M.; more...
    Cell Reports (2021)

    Fulltext@MSK | Save
  • TP53-stabilization with APR-246 enhances antitumor effects of immune checkpoint in preclinical models
    Meeting Abstract

    Ghosh, A.; Michel, J.; Dong, L.; Suek, N.; Zhong, H.; Budhu, S.; de Henau, O.; Wolchok, J.; Merghoub, T.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; DeHanau, O.; Mangarin, L. M.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budha, S.; Giese, R.; Gupta, A.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Barker, C.; Shan, J.; Wolchok, J. D.; Merghoub, T.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model
    Meeting Abstract

    Budhu, S.; Giese, R.; Gupta, A.; Schad, S.; De Henau, O.; Zappasodi, R.; Campesato, L.; Barker, C.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budhu, S.; Giese, R.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Gupta, A.; Barker, C.; Freimark, B.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save